Literature DB >> 26438015

Arthroplasty and postoperative antimicrobial prophylaxis.

Andrew M Morris1, Jeffrey Gollish2.   

Abstract

Mesh：

Year:  2015        PMID： 26438015      PMCID： PMC4771528          DOI： 10.1503/cmaj.150429

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  THE PROPHYLAXIS OF SURGICAL INFECTION: THE EFFECT OF PROPHYLACTIC ANTIMICROBIAL DRUGS ON THE INCIDENCE OF INFECTION FOLLOWING POTENTIALLY CONTAMINATED OPERATIONS.

Authors:  H R BERNARD; W R COLE
Journal:  Surgery       Date:  1964-07       Impact factor: 3.982

2.  Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Patrick Thornley; Nathan Evaniew; Michael Riediger; Mitchell Winemaker; Mohit Bhandari; Michelle Ghert
Journal:  CMAJ Open       Date:  2015-07-17

3.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.

Authors:  D C Classen; R S Evans; S L Pestotnik; S D Horn; R L Menlove; J P Burke
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  Antibiotic prophylaxis for total joint replacement surgery: results of a survey of Canadian orthopedic surgeons.

Authors:  Justin de Beer; Danielle Petruccelli; Coleman Rotstein; Brad Weening; Katie Royston; Mitch Winemaker
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

5.  Surgical site infection prevention following total hip arthroplasty in Australia: a cost-effectiveness analysis.

Authors:  Katharina M D Merollini; Ross W Crawford; Sarah L Whitehouse; Nicholas Graves
Journal:  Am J Infect Control       Date:  2013-02-21       Impact factor: 2.918

6.  Clostridium difficile in patients undergoing primary hip and knee replacement.

Authors:  P J Jenkins; K Teoh; P M Simpson; J Dave; A H W R Simpson; S Breusch
Journal:  J Bone Joint Surg Br       Date:  2010-07

7.  Cloxacillin in the prophylaxis of postoperative infections of the hip.

Authors:  C Ericson; L Lidgren; L Lindberg
Journal:  J Bone Joint Surg Am       Date:  1973-06       Impact factor: 5.284

8.  Use of Medicare claims to identify US hospitals with a high rate of surgical site infection after hip arthroplasty.

Authors:  Michael S Calderwood; Ken Kleinman; Dale W Bratzler; Allen Ma; Christina B Bruce; Rebecca E Kaganov; Claire Canning; Richard Platt; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-20       Impact factor: 3.254

9.  Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor.

Authors:  Marjo E E van Kasteren; Judith Manniën; Alewijn Ott; Bart-Jan Kullberg; Annette S de Boer; Inge C Gyssens
Journal:  Clin Infect Dis       Date:  2007-02-14       Impact factor: 9.079

Review 10.  A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty.

Authors:  Jiaxing Wang; Chen Zhu; Tao Cheng; Xiaochun Peng; Wen Zhang; Hui Qin; Xianlong Zhang
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240
View more
  2 in total

Review 1.  Chitosan and Hydroxyapatite Based Biomaterials to Circumvent Periprosthetic Joint Infections.

Authors:  Ana Rita Costa-Pinto; Ana Luísa Lemos; Freni Kekhasharú Tavaria; Manuela Pintado
Journal:  Materials (Basel)       Date:  2021-02-08       Impact factor: 3.623

2.  Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial).

Authors:  Tesfaye H Leta; Jan-Erik Gjertsen; Håvard Dale; Geir Hallan; Stein Håkon Låstad Lygre; Anne Marie Fenstad; Gro Sævik Dyrhovden; Marianne Westberg; Tina Stromdal Wik; Rune Bruhn Jakobsen; Arild Aamodt; Stephan Maximillian Röhrl; Øystein Johannes Gøthesen; Einar Lindalen; Stig Heir; Jarle Ludvigsen; Trond Bruun; Ann Kristin Hansen; Knut Erik Moen Aune; Marianne Warholm; John Petter Skjetne; Mona Badawy; Pål Høvding; Otto Schnell Husby; Øystein Espeland Karlsen; Ove Furnes
Journal:  BMJ Open       Date:  2021-01-28       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.